Cytotoxic effects of curcumin on osteosarcoma cell lines (original) (raw)
Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9:422–441 ArticlePubMed Google Scholar
Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, LaQuaglia M (1993) Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11:449–453 PubMedCAS Google Scholar
Weinfeld MS, Dudley HR (1962) Osteogenic sarcoma: a follow-up study of the ninety-four cases observed at the Massachusetts General Hospital from 1920 to 1960. Am J Orthop 44:269–276 Google Scholar
Friedman MA, Carter S (1972) The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol 4:482–510 ArticlePubMedCAS Google Scholar
Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J (1991) Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the multi-institutional osteosarcoma study. Clin Orthop Relat Res 270:8–14 PubMed Google Scholar
Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5:21–26 PubMedCAS Google Scholar
Baum ES, Gaynon P, Greenberg L, Krivit W, Hammond D (1981) Phase II trail cisplatin in refractory childhood cancer: children’s cancer study group report. Cancer Treat Rep 65:815–822 PubMedCAS Google Scholar
Smith MA, Ungerleider RS, Horowitz ME, Simon R (1991) Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing’s sarcoma. J Natl Cancer Inst 83:1460–1470 ArticlePubMedCAS Google Scholar
Meistrich ML, Chawla SP, da Cunha MF, Johnson SL, Plager C, Papadopoulos NE, Lipshultz LI, Benjamin RS (1989) Recovery of sperm production after chemotherapy for osteosarcoma. Cancer 63:2115–2123 ArticlePubMedCAS Google Scholar
Govindarajan VS (1980) Turmeric: chemistry, technology and quality. Crit Rev Food Sci Nutr 12:199–301 ArticlePubMedCAS Google Scholar
Amon HP, Wahl M (1991) Pharmacology of Curcuma longa. Plant Med 57:1–7 Article Google Scholar
Kunchandy E, Rao MNA (1990) Oxygen radical scavenging activity of curcumin. Int J Pharm 58:237–240 ArticleCAS Google Scholar
Chan MM, Huang HI, Fenton MR, Fong D (1998) In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55:1955–1962 ArticlePubMedCAS Google Scholar
Sharma RA, Gescher AJ, Steward W (2005) Curcumin: the story so far. Eur J Cancer 41:1955–1968 ArticlePubMedCAS Google Scholar
Aggarwal BB, Kumar A, Bharti A (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:3633–3698 Google Scholar
Dorai T, Gehani N, Katz A (2000) Therapeutic potential of curcumin in human prostate cancer. Prostate Cancer Dis 3:84–93 ArticleCAS Google Scholar
Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H, Ho CT (1998) Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[_a_]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 19:1967–1700 Google Scholar
Hanif R, Qiao L, Shiff SJ, Rigas B (1997) Curcumin, a natural plant phenolic food additive inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med 130:576–584 ArticlePubMedCAS Google Scholar
Johnson JJ, Mukhtar H (2007) Curcumin for chemoprevention of colon cancer. Cancer Lett 255:170–181 ArticlePubMedCAS Google Scholar
Walters DK, Muff R, Langsam B, Gruber P, Born W, Fuchs B (2007) Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines. Invest New Drugs 25:305–312 ArticlePubMedCAS Google Scholar
Boersma HH, Kietselaer B, Stolk L, Bennaghmouch A, Hofstra L, Narula J, Heidendal G, Reutelingsperger C (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46:2035–2050 PubMedCAS Google Scholar
Konopleva M, Zhao S, Xie Z, Segall H, Younes A, Claxton DF, Estrov Z, Kornblau SM, Andreeff M (1999) Apoptosis. Molecules and mechanisms. Adv Exp Med Biol 457:217–236 PubMedCAS Google Scholar
Shankar S, Srivastava RK (2007) Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Carcinogenesis 28:1277–1286 ArticlePubMedCAS Google Scholar
Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, Chou HY, Chien CT, Chen WJ, Lee YT, Yang PC (2004) Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 65:99–110 ArticlePubMedCAS Google Scholar
Jaiswal AS, Marlow BP, Gupta N, Narayan S (2002) Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuloylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21:8414–8427 ArticlePubMedCAS Google Scholar
Hsu CH, Cheng AL (2007) Clinical studies with curcumin. Adv Exp Med Biol 595:471–480 ArticlePubMed Google Scholar
Gupta KK, Bharne SS, Rathinasamy K, Naik NR, Panda D (2006) Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding. FEBS J 273:5320–5332 ArticlePubMedCAS Google Scholar
Kuo ML, Huang TS, Lin JK (1996) Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317:95–100 PubMedCAS Google Scholar
Chen H, Zhang ZS, Zhang YL, Zhou DH (1999) Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19:3675–3680 PubMedCAS Google Scholar
Mehta K, Pantazis P, McQueen T, Aggarwal DH (1997) Antiproliferative effects of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8:470–481 ArticlePubMedCAS Google Scholar
Er E, Oliver L, Cartron P-F, Juin P, Manon S, Vallette FM (2006) Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 1757:1301–1311 ArticlePubMedCAS Google Scholar
Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M, Lock RB (2000) Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 7:102–111 ArticlePubMedCAS Google Scholar
Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y (1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 95:14681–14686 ArticlePubMedCAS Google Scholar
Shankar S, Srivastava RK (2007) Involvement of Bcl-2 family members, phosphatidylinositol 3′-kinase/AKT and mitochondrial p53 in curcumin (diferuloylmethane)-induced apoptosis in prostate cancer. Int J Oncol 30:905–918 PubMedCAS Google Scholar
Mukherjee NCS, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Dey S, Roy M (2007) Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem 297:31–39 ArticleCAS Google Scholar
Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23:143–150 ArticlePubMedCAS Google Scholar
Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D, Alessandro N (2005) Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett 224:53–65 PubMedCAS Google Scholar
Bischt S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A (2007) Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. Journal of Nanobiotechnology 5:3 ArticleCAS Google Scholar